These results, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 support the notion of targeting ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated Ailments. A exploration examine released in https://seingalj114xmc2.dailyblogzz.com/profile